Sektor Novo Nordisk A/S

Aktien

A3EU6F

DK0062498333

NOVO B

Pharmazeutika

Markt geschlossen - Nasdaq Copenhagen 17:20:00 13.02.2026 % 5 Tage Veränd. 1. Jan.
310.60 DKK +1.32% Intraday Chart für Novo Nordisk A/S +5.11% -4.50%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. % 1 Jahr Veränd. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Kap.($)
+1.32%+5.11%-18.97%-2.53%-4.50%-45.12%-37.51%+35.04%+93.40% 219 Mrd.
+0.33%-1.72%-3.10%+1.44%-3.23%+23.18%+199.23%+401.71%+1’359.24% 929 Mrd.
-0.45%+1.44%+11.39%+24.25%+17.64%+55.91%+50.24%+46.15%+139.10% 587 Mrd.
+1.76%+3.61%+4.33%-0.37%+1.32%+20.03%+51.71%+121.66%+340.28% 409 Mrd.
+0.08%+1.01%+5.60%+24.18%+9.69%+20.89%+28.94%+14.94%+47.36% 374 Mrd.
+1.42%+7.19%+7.92%+12.03%+9.63%+26.36%+32.36%+102.36%+273.61% 320 Mrd.
+1.08%+4.32%+10.12%+18.35%+14.18%+27.98%+55.61%+52.61%+76.50% 311 Mrd.
+1.82%-0.43%+9.37%+30.66%+15.34%+46.26%+11.65%+61.88%+147.62% 301 Mrd.
+1.52%-3.94%+12.23%+9.64%+12.80%+26.80%+53.17%+55.64%+155.11% 199 Mrd.
+2.09%+1.63%+24.91%+23.96%+26.27%+48.90%+80.88%+131.69%+73.28% 192 Mrd.
+0.40%+1.32%+7.82%+10.06%+10.76%+8.03%-36.92%-20.56%-6.06% 157 Mrd.
+5.69%+2.84%+9.33%+12.43%+8.41%+7.07%+63.69%+129.68%+490.50% 125 Mrd.
+1.47%-2.02%+6.52%+30.20%+12.61%+12.69%-15.93%+1.25%+0.90% 124 Mrd.
+1.12%-1.50%+16.52%+19.58%+18.66%+49.88%+45.54%+35.52%+27.03% 118 Mrd.
-1.87%-3.41%-3.58%-14.18%-6.17%-26.33%-11.44%-0.69%+12.82% 111 Mrd.
+0.87%+7.81%+9.99%+14.67%+12.58%+27.91%+159.65%+80.30%+775.47% 99.9 Mrd.
+0.09%+1.76%+11.83%+28.17%+16.11%+34.24%+34.43%+52.22%+10.36% 58.01 Mrd.
-0.87%+1.61%-9.75%-8.39%-2.25%+30.44%+29.49%-36.01%+316.18% 55.97 Mrd.
+0.65%+0.40%+18.08%+53.62%+24.25%+112.70%-22.78%-14.76%-51.48% 53.62 Mrd.
+0.64%+2.79%+12.91%+8.69%+9.18%+4.57%+23.38% - - 49.67 Mrd.
Durchschnitt +0.96%+1.67%+7.17%+14.82%+10.16%+25.62%+39.77%+65.82%+225.33% 239.67 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung +0.86%+1.53%+5.58%+13.09%+8.32%+26.22%+66.64%+124.99%+396.43%
Pharmazeutika - Andere
  1. Börse
  2. Aktien
  3. A3EU6F Aktie
  4. Sektor Novo Nordisk A/S